U.S. Patent & Trademark Office USPTO Issues Patent To Elorac Inc. for Treating Chronic Inflammatory Disorders

Elorac Inc. a privately held specialty pharmaceutical company engaged in the development of novel products for dermatology allergy and oncology announced that the USPTO has issued to Elorac U.S. Patent No. 9545419 entitled Method an...